Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Raoul S Concepcion"'
Autor:
Neil M Schultz, Neal D Shore, Simon Chowdhury, Laurence H Klotz, Raoul S Concepcion, David F Penson, Lawrence I Karsh, Hongbo Yang, Bruce A Brown, Arie Barlev, Scott C Flanders
Publikováno v:
BMC Urology, Vol 18, Iss 1, Pp 1-1 (2018)
It has been highlighted that in the original article [1] there was a typesetting mistake in the Results – NNT in Strive section. This Correction article states the incorrect and correct sentence.
Externí odkaz:
https://doaj.org/article/9de2fcbbd4f74f6eb4c2185059fbb0ea
Autor:
E. David Crawford, Richard G. Harris, Susan F. Slovin, Raoul S. Concepcion, David M. Albala, Leonard G. Gomella, Peter F. Orio, Scott B. Sellinger, Daniel P. Petrylak, Phillip J. Koo
Publikováno v:
JU Open Plus. 1
Autor:
David F. Penson, Andrew J. Armstrong, Raoul S. Concepcion, Neeraj Agarwal, Carl A. Olsson, Lawrence I. Karsh, Curtis J. Dunshee, William Duggan, Qi Shen, Jennifer Sugg, Gabriel P. Haas, Celestia S. Higano
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:363-365
Background In the phase 2, randomized, double-blind STRIVE trial, enzalutamide significantly reduced the risk of prostate cancer progression or death versus bicalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) and non
Autor:
Charles G. Drake, Raoul S. Concepcion, Daniel W. Lin, Neal D. Shore, Michael B. Williams, Lawrence Karsh, Ken Kernen, Sanjeev Kaul, Charles J. Ryan, Curtis Dunshee, Christopher Michael Pieczonka, Christopher Stewart, Paul Sieber, Kelly L. Stratton
Publikováno v:
The Prostate. 80:1159-1176
Background Advanced prostate cancer (PC) patients, especially those with metastatic prostate cancer (mPC), often require complex management pathways. Despite the publication of clinical practice guidelines by leading urological and oncological organi
Autor:
Alicia K. Morgans, Jeffrey M. Spier, Michael S. Cookson, Jason Hafron, E. David Crawford, Gordon A. Brown, Jonathan Henderson, Emmanuel S. Antonarakis, Neal D. Shore, Daniel Saltzstein, Raoul S. Concepcion, David M. Albala, Benjamin H Lowentritt, Richard G. Harris
Publikováno v:
The Prostate
Background For specific clinical indications, androgen deprivation therapy (ADT) will induce disease prostate cancer (PC) regression, relieve symptoms and prolong survival; however, ADT has a well‐described range of side effects, which may have a d
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:CLO20-063
Autor:
Nancy N. Chang, Mark C. Scholz, Philip W. Kantoff, David I. Quinn, Matthew Harmon, Raoul S. Concepcion, Andrew J. Armstrong, Luke T. Nordquist, David F. Penson, Robert Claude Tyler, Ronald F. Tutrone, Neal D. Shore, Nicholas J. Vogelzang, Matthew R. Cooperberg, Vahan Kassabian, Celestia S. Higano, Hong Tang, Christopher Michael Pieczonka, David G. McLeod, A. Oliver Sartor, Jeffrey L. Vacirca
Publikováno v:
Cancer
Background The large registry, PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data (PROCEED)(NCT01306890), evaluated sipuleucel‐T immunotherapy for asymptomatic/minimally symptomatic metastatic castration‐resistan
Autor:
Neal D. Shore, Christopher Michael Pieczonka, R. Jonathan Henderson, James L. Bailen, Daniel R. Saltzstein, Raoul S. Concepcion, David Gillatt, Daniel W. Chan, Douglas Campbell, Yanling Lu, Thao Ho Le, Niantao Deng, Bradley Walsh
Publikováno v:
Journal of Clinical Oncology. 40:229-229
229 Background: Clinicians want a more accurate diagnostic test to identify patients for prostate biopsy. We have previously described the development of a Luminex based test for aggressive prostate cancer (MiCheck). To facilitate widespread deployme
Autor:
Scott T. Tagawa, Thomas E. Keane, Przemyslaw Twardowski, Raoul S. Concepcion, Daniel P. Petrylak, Jason Hafron, Chaundre K. Cross, Lucio N. Gordan, Judd W. Moul, A. Karim Kader, Neal D. Shore, Richard G. Harris, E. David Crawford, Celestia S. Higano
Publikováno v:
The Journal of urology. 205(2)
Nonadherence to dosing schedules for androgen deprivation therapy increases the risk of testosterone escape for patients with prostate cancer. Two approved formulations of leuprolide acetate, the most commonly prescribed androgen deprivation therapy
Autor:
Robert Pilarski, Arthur L. Burnett, Lucia R. Languino, Colette Hyatt, Jacqueline Powers, Robert B. Den, Alberto Briganti, Veda N. Giri, Lorelei A. Mucci, Daniel P. Petrylak, Oliver Sartor, Amie Blanco, Daniel W. Lin, Himisha Beltran, E. David Crawford, Karen E. Knudsen, Mary-Ellen Taplin, Brian T. Helfand, Felix Y. Feng, Costas D. Lallas, E. Michael D. Scott, Wayne H. Pinover, R. Jeffrey Karnes, Scott Weissman, Evan Y. Yu, Timothy R. Rebbeck, Ashley H. Woodson, Matthew J. Schiewer, Todd M. Morgan, William B. Isaacs, Jeffrey N. Weitzel, Alanna Kulchak Rahm, Michael S. Cookson, James A. Eastham, S. Bruce Malkowicz, Neha Vapiwala, Kevin R. Loughlin, Raoul S. Concepcion, Ana Maria Lopez, Jose Moreno, Brock O'Neil, Patrick T. Gomella, Patrick Mille, Charnita Zeigler-Johnson, Howard M. Sandler, Kathleen A. Cooney, William Tester, Sarah M. Nielsen, Thomas J. Polascik, Richard C. Wender, Howard R. Soule, Ronald E. Myers, Scott E. Eggener, Marc B. Garnick, Stacy Loeb, Martin Miner, Anthony J. Costello, Gerald L. Andriole, Amanda E. Toland, David Y.T. Chen, Albert Dobi, Joseph K Izes, Mary B. Daly, Leonard G. Gomella, Mark D. Hurwitz, J. Kellogg Parsons, Matthew L. Freedman, Nathan Handley, Adam P. Dicker, Jianfeng Xu, Michael Russell Mullane, Charles J. Ryan, Edouard J. Trabulsi, Anne Calvaresi, James Ryan Mark, Thenappan Chandrasekar, Colin C. Pritchard, Saud H. AlDubayan, Curtis A. Pettaway, William Kevin Kelly, Lindsey Byrne, Peter R. Carroll, Brittany M. Szymaniak, Alicia K. Morgans, Peter A. Pinto, William L. Dahut, Mark Mann, Ganesh V. Raj, James L. Mohler, Wendy Poage, Heather H. Cheng, Grace L. Lu-Yao
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 24
PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a0090e4e87cd120ef0899e6263c77c
https://escholarship.org/uc/item/3mg229rb
https://escholarship.org/uc/item/3mg229rb